Cellular responses to targeted radionuclide therapy: rethinking radiobiology under continuous low dose rates - Top-Institutions - MDSpire

Cellular responses to targeted radionuclide therapy: rethinking radiobiology under continuous low dose rates

  • By

  • Pleun A.M. Engbers

  • Julie Nonnekens

  • Mariangela Sabatella

  • July 17, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Radiology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Radiology

  • #3

    Weill Cornell Medicine
    Weill Cornell Medicine

    New York, New York

    Key Differentiators

    • Radiology

Original Source(s)

Cellular responses to targeted radionuclide therapy: rethinking radiobiology under continuous low dose rates

  • by Pleun A.M. Engbers, Julie Nonnekens, Mariangela Sabatella

  • July 17, 2026

Related Content

Correction: A mechanovascular framework for pre-neoplastic microenvironmental dysregulation and early carcinogenesis

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions

Cancer prevalence in the United States: trends and sociodemographic disparities based on national health interview survey data (2019–2023)